体成分评估(ABC)试验:男女一方体脂增加不显著影响体外受精实验室或临床结局
该前瞻性队列研究纳入2016年6月至2019年1月接受体外受精的1,889对不孕夫妇,在取卵时用生物电阻抗分析和体重指数评估体脂,追踪胚胎学与临床结局。结果显示女性肥胖仅轻微增加极低出生体重风险,多数胚胎学与妊娠结局与正常体重者相当;男性肥胖不影响任何胚胎学或临床结局。
要点
- 女性肥胖(体脂百分比或体重指数定义)不显著影响受精率、整倍体率、流产率、持续着床率或活产率。
- 体脂百分比定义的女性肥胖者囊胚形成率略高(55% vs 其他体脂类别51%),但体重指数定义的肥胖者无此趋势。
- 体脂百分比或体重指数定义的女性肥胖者极低出生体重率低但升高(3% vs 0%-1.3%)。
核心结论
- 女性肥胖仅轻微增加极低出生体重风险,多数胚胎学与妊娠结局与正常体重者相当。
- 男性肥胖似乎不影响体外受精、妊娠或分娩结局。
研究设计与样本
- 前瞻性队列研究,纳入2016年6月至2019年1月接受体外受精的1,889对不孕夫妇。
- 在取卵时对女性和男性伴侣进行生物电阻抗分析和体重指数测量,前瞻性追踪胚胎学与临床结局。
- 比较组按体脂百分比和体重指数类别划分。
主要发现
- 所有女性受精率和整倍体率相当。
- 体脂百分比定义的肥胖女性囊胚形成率略高(55%),其他体脂类别为51%,但体重指数定义的肥胖女性无此趋势。
- 所有女性流产率、持续着床率和活产率相当。
- 体脂百分比或体重指数定义的肥胖女性极低出生体重率低但升高(3%),体重不足、正常体重和超重女性为0%-1.3%。
- 男性肥胖不显著影响任何胚胎学或临床结局。
临床怎么用
- 女性肥胖不应被视为体外受精胚胎学或临床结局的显著不利因素。
- 男性肥胖不影响体外受精结局,无需为此调整临床决策。
- 肥胖女性妊娠后需关注极低出生体重风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of obesity as determined by bioelectric impedance analysis (BIA) and body mass index (BMI) on in vitro fertilization (IVF) laboratory and clinical outcomes. DESIGN: Prospective cohort study. SETTING: Academic-affiliated private practice. PATIENT(S): A total of 1,889 infertile couples undergoing IVF from June 2016 to January 2019. INTERVENTION(S): Female patients and male partners underwent BIA and BMI measurement at the time of oocyte retrieval. Embryology and clinical outcomes were prospectively tracked with comparison groups determined by percentage of body fat (%BF) and BMI categories. MAIN OUTCOME MEASURE(S): Fertilization rate, blastocyst formation rate, euploidy rate, miscarriage rate, sustained implantation rate, live birth rate, rates of low birth weight/very low birth weight, prematurity rates. RESULT(S): Fertilization rates and euploidy rates were equivalent among all women. Blastocyst formation rates were slightly higher (55%) in women with an obese %BF compared with all other %BF categories (51%); however, this trend was not noted in women defined as obese by BMI. Miscarriage rates, sustained implantation rates, and live birth rates were equivalent among all women. The rate of very low birth weight was low but increased in obese women (3%) versus underweight, normal-weight, and overweight counterparts (0%-1.3%) as determined by %BF and BMI. Obesity in men did not significantly affect any embryologic or clinical outcomes. CONCLUSION(S): Although maternal obesity imposes a small but increased risk of very low birth weight infants, most embryology and pregnancy outcomes are equivalent to normal weight patients. Paternal obesity does not appear to affect IVF, pregnancy, or delivery outcomes.
引用
- Kim J, Patounakis G, Juneau C, et al. The Appraisal of Body Content (ABC) trial: Increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes. Fertil Steril. 2021. PMID: 33581854. doi:10.1016/j.fertnstert.2020.12.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。